Second-Line Evolution: TKIs to Antibody–Drug Conjugates

This week, we continue our discussion about metastatic breast cancer, focusing on HER2+ disease.

Content:

- What is the data about recurrence of disease of different breast cancer subtypes?

- The history of how we got to our current standards of care

- Important trials to support our current treatment paradigm

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast